Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 2006

View Archived Issues

YM-201627 presented as a new agent for solid tumors

Preclinical experiments support use of desvenlafaxine for menopause symptoms

Increlex stability, structural features detailed

GTx reports on novel nonsteroidal selective androgen receptor modulators

Cardioprotective effects of a new exendin-4 analogue

Iplex shows promise in severe insulin resistance syndromes

Bremelanotide affects desire and arousal in female sexual arousal disorder patients

S-2367 shows efficacy in maintaining and continuing weight loss in obese subjects

Japanese submission for minodronic acid hydrate in osteoporosis

Pivotal study begins for HuMax-CD20 in NHL

Takeda licenses rights to Galaxy's anti-HGF antibody

Grant for study of alagebrium effects on renal function in diabetes patients

Antigenics and GSK expand license and supply agreements for QS-21 adjuvant

Approvable letter for Cellegesic

Pivotal study of Mozobil completes enrollment

PRX-08066 relaxes pulmonary arteries without affecting systemic blood pressure in rodents

Astemizole shows antimalarial potential in preclinical studies

JNJ-1250132: A unique progesterone receptor modulator

Hemopure submitted for U.K. approval

Avandamet approved for initial treatment of type 2 diabetes

FDA approves Emend for prevention of postoperative nausea and vomiting

Recent patents report novel vanilloid VR1 receptor antagonists

Recent patents disclose novel agents for HCV infection

Schizophrenia, depression, etc. targets of newly patented compounds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...